|
A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients Clinical Trials Information presented on Clinical Trials Search isn't intended to be a substitute for proven healthcare advice, trips or treatment using a real physician. We are not docs. Always confer with your mD on A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients Clinical research trials and A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectiveness of new drugs. The intention of the studies / projects is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector corporations to detect remedies for all forms of circumstances, like A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients. A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients Clinical Trials and other clinical trials allow for volunteers to undergo healthcare treatment options before they are available to the masses. Most times the participants receive treatment for free, and every now and again they are paid for their time. Occasionally there is a cost for a A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients clinical trial. Subjects typically recieve the finest healthcare available for their A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients condition. Hazards are a reality, nonetheless, and might include more or frequent mD trips, health risks (potentially life-endangering), and/or the treatment being ineffective. Trials are federally regulated with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients
A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients
For Condition: Diarrhea,HIV Infections
Status: Completed
Sponsor(s): Shaman Pharmaceuticals ,
Synopsis: To evaluate the efficacy, safety, and durability of response of SP-303 in decreasing stool weight in AIDS patients with diarrhea over 6 days of treatment.
Details:
Eligibility:
Study Type: Interventional, Treatment, Double-Blind, Safety Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Patients must have: - HIV infection meeting CDC criteria for AIDS. - History of diarrhea for greater than or equal to 14 days prior to screening period (Day 1). Required: On stable medical regimen.
Total Enrollment: 300
Location and Contact Information:
Oak Park Hosp
Oak Park, Illinois, 60304
United States
GCRC
Washington D.C., District of Columbia, 20060
United States
Ctr for Quality Care
Tampa, Florida, 33609
United States
San Francisco Gen Hosp
San Francisco, California, 94110
United States
Washington Univ School of Medicine
St. Louis, Missouri, 63110
United States
UCLA Care Ctr
Los Angeles, California, 90095
United States
Phoenix Living Ctr
Scottsdale, Arizona, 85251
United States
South Texas Veterans Health Care System
San Antonio, Texas, 78284
United States
Wayne State Univ
Detroit, Michigan, 48201
United States
New Orleans Pharmaceutical Research
Kenner, Louisiana, 70062
United States
Johns Hopkins Hosp
Baltimore, Maryland, 212875554
United States
Deering Hosp
Miami, Florida, 33157
United States
Central Florida Research Initiative
Maitland, Florida, 32751
United States
New England Med Ctr
Boston, Massachusetts, 02111
United States
Howard Univ
Washington D.C., District of Columbia, 20059
United States
Rosemont Health Care Ctr
Orlando, Florida, 32808
United States
Brookdale Univ Hosp and Med Ctr
Brooklyn, New York, 112123198
United States
Clinical Research Puerto Rico Inc
San Juan, , 00909
Puerto Rico
Joseph Gathe
Houston, Texas, 77004
United States
Wake Med CRI
Raleigh, North Carolina, 27610
United States
GCRC - VA Hosp
San Antonio, Texas, 78284
United States
Indiana Univ Med Ctr
Indianapolis, Indiana, 462025250
United States
Lynn House Hospice
West Hollywood, California, 90046
United States
Community CRI of South Florida
Coral Gables, Florida, 33146
United States
Hill Top Research Ltd
Scottsdale, Arizona, 85251
United States
Bailey Boushay House
Seattle, Washington, 98112
United States
AIDS Research Alliance
West Hollywood, California, 90069
United States
Regions Hosp
St. Paul, Minnesota, 55101
United States
Saint Vincents Hosp
New York City, New York, 10011
United States
Insite Clinical Trials
Decatur, Georgia, 30033
United States
Phillip Branchman
Atlanta, Georgia, 30327
United States
Rosehedge House
Seattle, Washington, 98125
United States
Mem Hosp of Tampa
Tampa, Florida, 33609
United States
AIDS Research Ctr / Dept of Veterans Affairs
Palo Alto, California, 94304
United States
Hennepin County Med Ctr
Minneapolis, Minnesota, 55415
United States
Hosp Regional de Ponce
Ponce, , 00731
Puerto Rico
Additional Information:
Study ID Numbers: 293A; 37,554-210
Study Start Date:
Record last reviewed: April 1999
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00002408
Other Hiv Infections Studies:
1. Invaplex 50 Vaccine Dose-Ranging
2. A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea
3. Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
4. A Randomized Trial of Tap Water Treatment in the Elderly
5. Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis
Related Studies:
Other HIV Infections Clinical Trials
Other Clinical Trials
Other San Juan Clinical Trials
A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients
|
|
|
|
|
|
|
|